Tim Middleton

704 total citations
20 papers, 499 citations indexed

About

Tim Middleton is a scholar working on Infectious Diseases, Hepatology and Molecular Biology. According to data from OpenAlex, Tim Middleton has authored 20 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Tim Middleton's work include HIV/AIDS drug development and treatment (12 papers), Hepatitis C virus research (11 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Tim Middleton is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), Hepatitis C virus research (11 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Tim Middleton collaborates with scholars based in United States, United Kingdom and Australia. Tim Middleton's co-authors include Dale J. Kempf, Warren M. Kati, Bill Sugden, Jennifer M. Martin, Akhteruzzaman Molla, David A. Egan, Terry Robins, Jürgen Dinges, Thomas F. Holzman and Karl A. Walter and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tim Middleton

19 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Middleton United States 13 187 180 155 130 90 20 499
Sandrine Vendeville France 11 184 1.0× 135 0.8× 144 0.9× 195 1.5× 174 1.9× 15 519
Jean Gauthier Canada 14 204 1.1× 245 1.4× 194 1.3× 206 1.6× 194 2.2× 31 728
Sadayappan V. Rahavendran United States 13 170 0.9× 112 0.6× 102 0.7× 82 0.6× 89 1.0× 18 506
Brian M. Beyer United States 12 221 1.2× 214 1.2× 134 0.9× 129 1.0× 54 0.6× 19 558
Oleg Brodsky United States 6 236 1.3× 172 1.0× 58 0.4× 102 0.8× 90 1.0× 7 438
Constantin G. Yannopoulos Canada 11 286 1.5× 431 2.4× 290 1.9× 229 1.8× 113 1.3× 12 732
Roger Maurice Canada 11 197 1.1× 475 2.6× 223 1.4× 281 2.2× 33 0.4× 15 699
Daniel P. Larson United States 10 222 1.2× 154 0.9× 68 0.4× 106 0.8× 141 1.6× 23 525
John Pichardo United States 15 163 0.9× 205 1.1× 146 0.9× 120 0.9× 153 1.7× 30 458
Ted Halmos Canada 12 255 1.4× 451 2.5× 252 1.6× 215 1.7× 202 2.2× 15 747

Countries citing papers authored by Tim Middleton

Since Specialization
Citations

This map shows the geographic impact of Tim Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Middleton more than expected).

Fields of papers citing papers by Tim Middleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Middleton. The network helps show where Tim Middleton may publish in the future.

Co-authorship network of co-authors of Tim Middleton

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Middleton. A scholar is included among the top collaborators of Tim Middleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Middleton. Tim Middleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lambert, Tim, Tim Middleton, Roger Chen, & Premala Sureshkumar. (2023). Prevalence of, and factors associated with, diabetes mellitus in people with severe mental illness attending a multidisciplinary, outpatient cardiometabolic health assessment service. BMJ Open Diabetes Research & Care. 11(1). e003055–e003055. 4 indexed citations
2.
Duru, O. Kenrik, et al.. (2018). The Landscape of Diabetic Kidney Disease in the United States. Current Diabetes Reports. 18(3). 14–14. 45 indexed citations
3.
Middleton, Tim. (2013). Joseph Conrad.
4.
Hutchinson, Douglas K., Charles A. Flentge, Rolf Wagner, et al.. (2011). Hepatitis C NS5B polymerase inhibitors: Functional equivalents for the benzothiadiazine moiety. Bioorganic & Medicinal Chemistry Letters. 21(6). 1876–1879. 7 indexed citations
5.
Hutchinson, Douglas K., Larry L. Klein, Daniel P. Larson, et al.. (2008). Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives. Bioorganic & Medicinal Chemistry Letters. 18(14). 3887–3890. 13 indexed citations
6.
Larson, Daniel P., Rolf Wagner, Todd W. Rockway, et al.. (2007). Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 568–570. 16 indexed citations
7.
Konstantinidis, Alex K., Paul L. Richardson, Rakesh Tripathi, et al.. (2007). Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease. Analytical Biochemistry. 368(2). 156–167. 9 indexed citations
8.
Middleton, Tim, Yupeng He, Edward Tam, et al.. (2007). A replicon-based shuttle vector system for assessing the phenotype of HCV NS5B polymerase genes isolated from patient populations. Journal of Virological Methods. 145(2). 137–145. 25 indexed citations
9.
Krueger, A. Chris, Darold L. Madigan, Douglas K. Hutchinson, et al.. (2007). Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives. Bioorganic & Medicinal Chemistry Letters. 17(8). 2289–2292. 17 indexed citations
10.
Chen, Chih‐Ming, Yupeng He, Liangjun Lu, et al.. (2007). Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model. Antimicrobial Agents and Chemotherapy. 51(12). 4290–4296. 39 indexed citations
11.
12.
Tripathi, Rakesh, Preethi Krishnan, Yupeng He, et al.. (2006). Replication efficiency of chimeric replicon containing NS5A–5B genes derived from HCV-infected patient sera. Antiviral Research. 73(1). 40–49. 27 indexed citations
13.
Krueger, A. Chris, Darold L. Madigan, Wen Jiang, et al.. (2006). Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides. Bioorganic & Medicinal Chemistry Letters. 16(13). 3367–3370. 24 indexed citations
14.
Pratt, John K., Keith F. McDaniel, Clarence J. Maring, et al.. (2005). Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines. Bioorganic & Medicinal Chemistry Letters. 15(6). 1577–1582. 28 indexed citations
15.
Xuei, Xiaoling, Tim Middleton, Ron Pithawalla, et al.. (2003). Use of SAM2® Biotin Capture Membrane in Microarrayed Compound Screening (μARCS) Format for Nucleic Acid Polymerization Assays. SLAS DISCOVERY. 8(3). 273–282. 6 indexed citations
16.
Middleton, Tim, Debra Montgomery, Hock Ben Lim, et al.. (2002). Microarray Compound Screening (<I>μ</I>ARCS) to Identify Inhibitors of HIV Integrase. 7(3). 259–266. 1 indexed citations
17.
Middleton, Tim, Debra Montgomery, Hock Ben Lim, et al.. (2002). Microarray Compound Screening (μARCS) to Identify Inhibitors of HIV Integrase. SLAS DISCOVERY. 7(3). 259–266. 24 indexed citations
18.
Hajduk, Philip J., Jürgen Dinges, Tim Middleton, et al.. (1997). NMR-Based Discovery of Lead Inhibitors That Block DNA Binding of the Human Papillomavirus E2 Protein. Journal of Medicinal Chemistry. 40(20). 3144–3150. 128 indexed citations
19.
Middleton, Tim, et al.. (1991). Immortalizing Genes of Epstein-Barr Virus. Advances in virus research. 40. 19–55. 55 indexed citations
20.
Middleton, Tim, Walter C. Herlihy, Paul Schimmel, & Hamish N. Munro. (1985). Synthesis and purification of oligoribonucleotides using T4 RNA ligase and reverse-phase chromatography. Analytical Biochemistry. 144(1). 110–117. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandrine Vendeville Breakdown of academic impact, for papers by Jean Gauthier Breakdown of academic impact, for papers by Sadayappan V. Rahavendran Breakdown of academic impact, for papers by Brian M. Beyer Breakdown of academic impact, for papers by Oleg Brodsky Breakdown of academic impact, for papers by Constantin G. Yannopoulos Breakdown of academic impact, for papers by Roger Maurice Breakdown of academic impact, for papers by Daniel P. Larson Breakdown of academic impact, for papers by John Pichardo Breakdown of academic impact, for papers by Ted Halmos
Rankless by CCL
2026